Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Lifecore Biomedical Inc

LFCR ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: BUY

Last Close

$4.72

▼ -0.21%

Market Cap $178.67M · Vol 25.55K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$178.67M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

62.03

Momentum

Beta

1.09

vs Market

52W High

$8.93

47.14% below

52W Low

$3.63

30.03% above

Volume

25.55K

Avg 55.90K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

97.32%

Public shares

Shariah Compliance8 STANDARDS

✗ Lifecore Biomedical Inc (LFCR) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LFCR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.79%

+2.39%

+3.74%

-33.33%

YTD

-42.30%

-36.39%

-50.73%

-55.97%

Financials & Valuation

TTM · Annual

Total Revenue	$75.52M
Net Income	$-17,961,000.00
Revenue Growth (YoY)	-6.25%
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	2.36
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	37.85M

Technical Indicators

50-Day SMA	$4.97
200-Day SMA	$6.14
RSI (14)	62.03
Beta	1.09
52-Week High	$8.93
52-Week Low	$3.63

Volume Today	25.55K
Avg Daily Volume (30D)	55.90K
Relative Volume	0.46x
Volatility (10D)	62.27
Volatility (30D)	51.72
Free Float	97.32%

Analyst Consensus

BUY

Current Price $4.72

Mean Target $6.75

52W Low$3.63 52W High$8.93

Current

Target

$3.63 $8.93

Current Analyst target

+43.01% upside potential · 5 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S7VTL0

ISINUS5147661046

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 1, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization that provides services in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes, vials and cartridges. It manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. It manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. It also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.